The JI
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     
 

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Sogabe, H.
Right arrow Articles by Song, W.-C.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Sogabe, H.
Right arrow Articles by Song, W.-C.
The Journal of Immunology, 2001, 167: 2791-2797.
Copyright © 2001 by The American Association of Immunologists

Increased Susceptibility of Decay-Accelerating Factor Deficient Mice to Anti-Glomerular Basement Membrane Glomerulonephritis1

Hajime Sogabe*, Masaomi Nangaku2,*, Yoshitaka Ishibashi*, Takehiko Wada*, Toshiro Fujita*, Xiujun Sun{dagger}, Takashi Miwa{dagger}, Michael P. Madaio{ddagger} and Wen-Chao Song2,{dagger}

* Division of Nephrology and Endocrinology, University of Tokyo School of Medicine, Tokyo, Japan; and {dagger} Center for Experimental Therapeutics and Departmentof Pharmacology, and {ddagger} Renal-Electrolyte and Hypertension Division, University of Pennsylvania School of Medicine, Philadelphia, PA 19104

To prevent complement-mediated autologous tissue damage, host cells express a number of membrane-bound complement inhibitors. Decay-accelerating factor (DAF, CD55) is a GPI-linked membrane complement regulator that is widely expressed in mammalian tissues including the kidney. DAF inhibits the C3 convertase of both the classical and alternative pathways. Although DAF deficiency contributes to the human hematological syndrome paroxysmal nocturnal hemoglobinuria, the relevance of DAF in autoimmune tissue damage such as immune glomerulonephritis remains to be determined. In this study, we have investigated the susceptibility of knockout mice that are deficient in GPI-anchored DAF to nephrotoxic serum nephritis. Injection of a subnephritogenic dose of rabbit anti-mouse glomerular basement membrane serum induced glomerular disease in DAF knockout mice but not in wild-type controls. When examined at 8 days after anti-glomerular basement membrane treatment, DAF knockout mice had a much higher percentage of diseased glomeruli than wild-type mice (68.8 ± 25.0 vs 10.0 ± 3.5%; p < 0.01). Morphologically, DAF knockout mice displayed increased glomerular volume (516 ± 68 vs 325 ± 18 x 103 µm3 per glomerulus; p < 0.0001) and cellularity (47.1 ± 8.9 vs 32.0 ± 3.1 cells per glomerulus; p < 0.01). Although the blood urea nitrogen level showed no difference between the two groups, proteinuria was observed in the knockout mice but not in the wild-type mice (1.4 ± 0.7 vs 0.02 ± 0.01 mg/24 h albumin excretion). The morphological and functional abnormalities in the knockout mouse kidney were associated with evidence of increased complement activation in the glomeruli. These results support the conclusion that membrane C3 convertase inhibitors like DAF play a protective role in complement-mediated immune glomerular damage in vivo.




This article has been cited by other articles:


Home page
 Nephrol Dial TransplantHome page
M. Mack
Podocyte antigens, dendritic cells and T cells contribute to renal injury in newly developed mouse models of glomerulonephritis
Nephrol. Dial. Transplant., October 1, 2009; 24(10): 2984 - 2986.
[Full Text] [PDF]

Home page
 Am. J. Pathol.Home page
V. W.Y. Leung, S. Yun, M. Botto, J. C. Mason, T. H. Malik, W. Song, D. Paixao-Cavalcante, M. C. Pickering, J. J. Boyle, and D. O. Haskard
Decay-Accelerating Factor Suppresses Complement C3 Activation and Retards Atherosclerosis in Low-Density Lipoprotein Receptor-Deficient Mice
Am. J. Pathol., October 1, 2009; 175(4): 1757 - 1767.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
J. Irie, B. Reck, Y. Wu, L. S. Wicker, S. Howlett, D. Rainbow, E. Feingold, and W. M. Ridgway
Genome-Wide Microarray Expression Analysis of CD4+ T Cells from Nonobese Diabetic Congenic Mice Identifies Cd55 (Daf1) and Acadl as Candidate Genes for Type 1 Diabetes
J. Immunol., January 15, 2008; 180(2): 1071 - 1079.
[Abstract] [Full Text] [PDF]

Home page
 BloodHome page
Y. Kimura, T. Miwa, L. Zhou, and W.-C. Song
Activator-specific requirement of properdin in the initiation and amplification of the alternative pathway complement
Blood, January 15, 2008; 111(2): 732 - 740.
[Abstract] [Full Text] [PDF]

Home page
 BloodHome page
X. Zhang, Y. Kimura, C. Fang, L. Zhou, G. Sfyroera, J. D. Lambris, R. A. Wetsel, T. Miwa, and W.-C. Song
Regulation of Toll-like receptor-mediated inflammatory response by complement in vivo
Blood, July 1, 2007; 110(1): 228 - 236.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Pathol.Home page
T. Miwa, M. A. Maldonado, L. Zhou, K. Yamada, G. S. Gilkeson, R. A. Eisenberg, and W.-C. Song
Decay-Accelerating Factor Ameliorates Systemic Autoimmune Disease in MRL/lpr Mice via Both Complement-Dependent and -Independent Mechanisms
Am. J. Pathol., April 1, 2007; 170(4): 1258 - 1266.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
N. S. Bora, S. Kaliappan, P. Jha, Q. Xu, B. Sivasankar, C. L. Harris, B. P. Morgan, and P. S. Bora
CD59, a Complement Regulatory Protein, Controls Choroidal Neovascularization in a Mouse Model of Wet-Type Age-Related Macular Degeneration
J. Immunol., February 1, 2007; 178(3): 1783 - 1790.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
P. Jha, J.-H. Sohn, Q. Xu, Y. Wang, H. J. Kaplan, P. S. Bora, and N. S. Bora
Suppression of Complement Regulatory Proteins (CRPs) Exacerbates Experimental Autoimmune Anterior Uveitis (EAAU).
J. Immunol., June 15, 2006; 176(12): 7221 - 7231.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Cell Physiol.Home page
E. A. Lidington, R. Steinberg, A. R. Kinderlerer, R. C. Landis, M. Ohba, A. Samarel, D. O. Haskard, and J. C. Mason
A role for proteinase-activated receptor 2 and PKC-{epsilon} in thrombin-mediated induction of decay-accelerating factor on human endothelial cells
Am J Physiol Cell Physiol, December 1, 2005; 289(6): C1437 - C1447.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Microbiol. Rev.Home page
A. L. Servin
Pathogenesis of Afa/Dr Diffusely Adhering Escherichia coli
Clin. Microbiol. Rev., April 1, 2005; 18(2): 264 - 292.
[Abstract] [Full Text] [PDF]

Home page
 JEMHome page
J. Liu, T. Miwa, B. Hilliard, Y. Chen, J. D. Lambris, A. D. Wells, and W.-C. Song
The complement inhibitory protein DAF (CD55) suppresses T cell immunity in vivo
J. Exp. Med., February 22, 2005; 201(4): 567 - 577.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
V. R. Holla, D. Wang, J. R. Brown, J. R. Mann, S. Katkuri, and R. N. DuBois
Prostaglandin E2 Regulates the Complement Inhibitor CD55/Decay-accelerating Factor in Colorectal Cancer
J. Biol. Chem., January 7, 2005; 280(1): 476 - 483.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
J. C. Mason, R. Steinberg, E. A. Lidington, A. R. Kinderlerer, M. Ohba, and D. O. Haskard
Decay-accelerating Factor Induction on Vascular Endothelium by Vascular Endothelial Growth Factor (VEGF) Is Mediated via a VEGF Receptor-2 (VEGF-R2)- and Protein Kinase C-{alpha}/{epsilon} (PKC{alpha}/{epsilon})-dependent Cytoprotective Signaling Pathway and Is Inhibited by Cyclosporin A
J. Biol. Chem., October 1, 2004; 279(40): 41611 - 41618.
[Abstract] [Full Text] [PDF]

Home page
 J. Am. Soc. Nephrol.Home page
T. Ohse, T. Ota, N. Kieran, C. Godson, K. Yamada, T. Tanaka, T. Fujita, and M. Nangaku
Modulation of Interferon-Induced Genes by Lipoxin Analogue in Anti-Glomerular Basement Membrane Nephritis
J. Am. Soc. Nephrol., April 1, 2004; 15(4): 919 - 927.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
F. Lin, D. J. Salant, H. Meyerson, S. Emancipator, B. P. Morgan, and M. E. Medof
Respective Roles of Decay-Accelerating Factor and CD59 in Circumventing Glomerular Injury in Acute Nephrotoxic Serum Nephritis
J. Immunol., February 15, 2004; 172(4): 2636 - 2642.
[Abstract] [Full Text] [PDF]

Home page
 J. Am. Soc. Nephrol.Home page
D. Turnberg, M. Botto, J. Warren, B. P. Morgan, Mark. J. Walport, and H. T. Cook
CD59a Deficiency Exacerbates Accelerated Nephrotoxic Nephritis in Mice
J. Am. Soc. Nephrol., September 1, 2003; 14(9): 2271 - 2279.
[Abstract] [Full Text] [PDF]

Home page
 J. Am. Soc. Nephrol.Home page
M. Nangaku
Complement Regulatory Proteins: Are They Important in Disease?
J. Am. Soc. Nephrol., September 1, 2003; 14(9): 2411 - 2413.
[Full Text] [PDF]

Home page
 Physiol. Rev.Home page
H. Pavenstadt, W. Kriz, and M. Kretzler
Cell Biology of the Glomerular Podocyte
Physiol Rev, January 1, 2003; 83(1): 253 - 307.
[Abstract] [Full Text] [PDF]

Home page
 Circ. Res.Home page
J. C. Mason, Z. Ahmed, R. Mankoff, E. A. Lidington, S. Ahmad, V. Bhatia, A. Kinderlerer, A. M. Randi, and D. O. Haskard
Statin-Induced Expression of Decay-Accelerating Factor Protects Vascular Endothelium Against Complement-Mediated Injury
Circ. Res., October 18, 2002; 91(8): 696 - 703.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Pathol.Home page
T. Miwa, M. A. Maldonado, L. Zhou, X. Sun, H. Y. Luo, D. Cai, V. P. Werth, M. P. Madaio, R. A. Eisenberg, and W.-C. Song
Deletion of Decay-Accelerating Factor (CD55) Exacerbates Autoimmune Disease Development in MRL/lpr Mice
Am. J. Pathol., September 1, 2002; 161(3): 1077 - 1086.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Website Copyright © 2001 by The American Association of Immunologists, Inc. All rights reserved.
All Contents Copyright © 2001 by The American Association of Immunologists, Inc. All rights reserved.